https://www.republicworld.com/health/what-is-yartemlea-fda-approves-omeros-medicine-to-treat-ta-tma-dangerous-post-transplant-disorder-in-adults-and-children
Dec 25, 2025 - TA-TMA occurs due to damaged blood vessels during or after a stem cell transplant as a result of an overactive immune system, causing inflammation. This leads...
what isyartemleafdaomerosmedicine